Peab Builds Apartments in Espoo

Peab has been commissioned to build 137 apartments on Uuno Kailas Road 4 in Espoo for the Kojamo Group. The contract is worth EUR 15 million.

Marko Rinkinen, Region Manager, Peab, Finland.

The project consists of a high-rise with five to eight floors and four staircases with 137 high class apartments with one to four rooms. Peab has previously built homes for Kojamo in the same tract.

“In recent years we have built a number of high class high rises in the capital city region together with Kojamo. We are very pleased that our excellent cooperation will continue in this project and that we can contribute to fulfilling the need for more housing in Espoo,” says Region Manager Marko Rinkinen, Peab Finland.

The project is a turnkey contract. Construction will begin in May 2020 and occupation is planned for January 2022.

The project will be order registered in the second quarter of 2020.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Peab AB. (2020, May 14). Peab Builds Apartments in Espoo. AZoBuild. Retrieved on December 02, 2024 from https://www.azobuild.com/news.aspx?newsID=23090.

  • MLA

    Peab AB. "Peab Builds Apartments in Espoo". AZoBuild. 02 December 2024. <https://www.azobuild.com/news.aspx?newsID=23090>.

  • Chicago

    Peab AB. "Peab Builds Apartments in Espoo". AZoBuild. https://www.azobuild.com/news.aspx?newsID=23090. (accessed December 02, 2024).

  • Harvard

    Peab AB. 2020. Peab Builds Apartments in Espoo. AZoBuild, viewed 02 December 2024, https://www.azobuild.com/news.aspx?newsID=23090.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.